These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9077483)

  • 1. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S; Li XY; Duell EA; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):513-8. PubMed ID: 9077483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF; Langman MJ; Williams GR
    Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3.
    Zou A; Elgort MG; Allegretto EA
    J Biol Chem; 1997 Jul; 272(30):19027-34. PubMed ID: 9228086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR
    Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
    Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
    Sørensen S; Sølvsten H; Politi Y; Kragballe K
    Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
    Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
    Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1alpha,25-dihydroxyvitamin D3.
    Akeno N; Saikatsu S; Kawane T; Horiuchi N
    Endocrinology; 1997 Jun; 138(6):2233-40. PubMed ID: 9165006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D(3) and 9-cis-retinoids are synergistic regulators of 24-hydroxylase activity in the rat and 1, 25-dihydroxyvitamin D(3) alters retinoic acid metabolism in vivo.
    Reinhardt TA; Koszewski NJ; Omdahl J; Horst RL
    Arch Biochem Biophys; 1999 Aug; 368(2):244-8. PubMed ID: 10441374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes.
    Chen ML; Heinrich G; Ohyama YI; Okuda K; Omdahl JL; Chen TC; Holick MF
    Proc Soc Exp Biol Med; 1994 Oct; 207(1):57-61. PubMed ID: 7938037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
    Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
    Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
    Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
    Gamblin GT; Liberman UA; Eil C; Downs RW; DeGrange DA; Marx SJ
    J Clin Invest; 1985 Mar; 75(3):954-60. PubMed ID: 3872316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.